An integrated genotyping approach for HLA and other complex genetic systems

Human Immunology

Volumn 76, Issue 12, 2015, Pages 928-938

  Nelson, Wyatt C ^a,b   Pyo, Chul Woo ^a,b   Vogan, David ^a,b   Wang, Ruihan ^a,b   Pyon, Yoon Soo ^a   Hennessey, Carly ^a   Smith, Anajane ^b   Pereira, Shalini ^b   Ishitani, Akiko ^b,c   Geraghty, Daniel E ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Scisco Genetics Inc   (United States)

^c Scisco Genetics Inc   (Japan)

Author keywords

Genotyping software; High resolution; HLA genotyping; KIR haplotyping; Multiplex PCR; Single molecule sequencing; System integration

Indexed keywords

DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; HLA DRB5 ANTIGEN; UNCLASSIFIED DRUG; HLA ANTIGEN;

AMPLICON; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD; DRIED BLOOD SPOT TESTING; GENE LOCUS; GENE SEQUENCE; GENETIC ALGORITHM; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOGENETICS; INTRON; LYMPHOBLASTOID CELL LINE; NULL ALLELE; ORAL BIOPSY; PRIORITY JOURNAL; ALLELE; BIOLOGY; DNA SEQUENCE; EXON; GENETICS; GENOTYPING TECHNIQUE; HIGH THROUGHPUT SEQUENCING; HISTOCOMPATIBILITY TEST; PROCEDURES; REPRODUCIBILITY; SOFTWARE; STANDARDS; WORKFLOW;

ALLELES; COMPUTATIONAL BIOLOGY; EXONS; GENOTYPE; GENOTYPING TECHNIQUES; HAPLOTYPES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; SOFTWARE; WORKFLOW;

EID: 84959114986     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.05.001     Document Type: Article

References (55)

1. Fernandez-Vina M.A., Wang T., Lee S.J., Haagenson M., Aljurf M., Askar M., et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood 2014, 123:1270.
2. Petersdorf E.W., Malkki M., Hsu K., Bardy P., Cesbron A., Dickinson A., et al. 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. Int. J. Immunogenet. 2013, 40:2.
3. *1454 in South German Caucasians. Tissue Antigens 2010, 76:57.
4. Lee S.J., Klein J., Haagenson M., Baxter-Lowe L.A., Confer D.L., Eapen M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576.
5. Spellman S.R., Eapen M., Logan B.R., Mueller C., Rubinstein P., Setterholm M.I., et al. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood 2012, 120:259.
6. Dehn J., Arora M., Spellman S., Setterholm M., Horowitz M., Confer D., et al. Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match. Biol. Blood Marrow Transplant. 2008, 14:1334.
7. MacMillan M.L., Davies S.M., Nelson G.O., Chitphakdithai P., Confer D.L., King R.J., et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol. Blood Marrow Transplant. 2008, 14:16.
8. Sasazuki T., Juji T., Morishima Y., Kinukawa N., Kashiwabara H., Inoko H., et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N. Engl. J. Med. 1998, 339:1177.
9. Hansen J.A., Gooley T.A., Martin P.J., Appelbaum F., Chauncey T.R., Clift R.A., et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N. Engl. J. Med. 1998, 338:962.
10. Venepalli N., Rezvani K., Mielke S., Savani B.N. Role of allo-SCT for CML in 2010. Bone Marrow Transplant. 2010, 45:1579.
11. Latham K., Little A.M., Madrigal J.A. An overview of HLA typing for hematopoietic stem cell transplantation. Methods Mol. Biol. 2014, 1109:73.
12. Voorter C.E., Palusci F., Tilanus M.G. Sequence-based typing of HLA: an improved group-specific full-length gene sequencing approach. Methods Mol. Biol. 2014, 1109:101.
13. Grumbt B., Eck S.H., Hinrichsen T., Hirv K. Diagnostic applications of next generation sequencing in immunogenetics and molecular oncology. Transfus. Med. Hemother. 2013, 40:196.
14. McCann S.R., Crampe M., Molloy K., Lawler M. Hemopoietic chimerism following stem cell transplantation. Transfus. Apher. Sci. 2005, 32:55.
15. Aydin F., Oguz F., Onal A.E., Bilgen H., Oguz R., Anak S., et al. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation. Int. J. Lab. Hematol. 2007, 29:208.
16. Kwon M., Martinez-Laperche C., Infante M., Carretero F., Balsalobre P., Serrano D., et al. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism. Biol. Blood Marrow Transplant. 2012, 18:1235.
17. Erlich H. HLA DNA typing: past, present, and future. Tissue Antigens 2012, 80:1.
18. Danzer M., Niklas N., Stabentheiner S., Hofer K., Proll J., Stuckler C., et al. Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnostics. BMC Genomics 2013, 14:221.
19. Niklas N., Proll J., Danzer M., Stabentheiner S., Hofer K., Gabriel C. Routine performance and errors of 454 HLA exon sequencing in diagnostics. BMC Bioinformatics 2013, 14:176.
20. Wang C., Krishnakumar S., Wilhelmy J., Babrzadeh F., Stepanyan L., Su L.F., et al. High-throughput, high-fidelity HLA genotyping with deep sequencing. Proc. Natl. Acad. Sci. USA 2012, 109:8676.
21. Lind C., Ferriola D., Mackiewicz K., Heron S., Rogers M., Slavich L., et al. Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing. Hum. Immunol. 2010, 71:1033.
22. Ehrenberg P.K., Geretz A., Baldwin K.M., Apps R., Polonis V.R., Robb M.L., et al. High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging. BMC Genomics 2014, 15:864.
23. Lind C., Ferriola D., Mackiewicz K., Papazoglou A., Sasson A., Monos D., et al. Filling the gaps - the generation of full genomic sequences for 15 common and well-documented HLA class I alleles using next-generation sequencing technology A multi-site study using high-resolution HLA genotyping by next generation sequencing. Hum. Immunol. 2013, 74:325.
24. Hosomichi K., Jinam T.A., Mitsunaga S., Nakaoka H., Inoue I. Phase-defined complete sequencing of the HLA genes by next-generation sequencing. BMC Genomics 2013, 14:355.
25. Lange V., Bohme I., Hofmann J., Lang K., Sauter J., Schone B., et al. Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing. BMC Genomics 2014, 15:63.
26. Smith A.G., Pyo C.W., Nelson W., Gow E., Wang R., Shen S., et al. Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors. Hum. Immunol. 2014, 75:1040.
27. Moonsamy P.V., Williams T., Bonella P., Holcomb C.L., Hoglund B.N., Hillman G., et al. High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array System for simplified amplicon library preparation. Tissue Antigens 2013, 81:141.
28. Chang C.X., Tan A.T., Or M.Y., Toh K.Y., Lim P.Y., Chia A.S., et al. Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases. Eur. J. Immunol. 2013, 43:1109.
29. Bentley D.R., Balasubramanian S., Swerdlow H.P., Smith G.P., Milton J., Brown C.G., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008, 456:53.
30. Gabriel C., Furst D., Fae I., Wenda S., Zollikofer C., Mytilineos J., et al. HLA typing by next-generation sequencing -- getting closer to reality. Tissue Antigens 2014, 83:65.
31. De Santis D., Dinauer D., Duke J., Erlich H.A., Holcomb C.L., Lind C., et al. 16(th) IHIW: review of HLA typing by NGS. Int. J. Immunogenet. 2013, 40:72.
32. Rothberg J.M., Hinz W., Rearick T.M., Schultz J., Mileski W., Davey M., et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011, 475:348.
33. Holcomb C.L., Hoglund B., Anderson M.W., Blake L.A., Bohme I., Egholm M., et al. A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens 2011, 77:206.
34. Erlich R.L., Jia X., Anderson S., Banks E., Gao X., Carrington M., et al. Next-generation sequencing for HLA typing of class I loci. BMC Genomics 2011, 12:42.
35. Trachtenberg E.A., Holcomb C.L. Next-generation HLA sequencing using the 454 GS FLX system. Methods Mol. Biol. 2013, 1034:197.
36. Saavedra-Matiz C.A., Isabelle J.T., Biski C.K., Duva S.J., Sweeney M.L., Parker A.L., et al. Cost-effective and scalable DNA extraction method from dried blood spots. Clin. Chem. 2013, 59:1045.
37. Adey A., Morrison H.G., Asan Xun X., Kitzman J.O., Turner E.H., et al. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol 2010, 11:R119.
38. Holcomb C.L., Rastrou M., Williams T.C., Goodridge D., Lazaro A.M., Tilanus M., et al. Next-generation sequencing can reveal in vitro-generated PCR crossover products: some artifactual sequences correspond to HLA alleles in the IMGT/HLA database. Tissue Antigens 2014, 83:32.
39. Robinson J., Halliwell J.A., Hayhurst J.D., Flicek P., Parham P., Marsh S.G. The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res. 2015, 43:D423.
40. Smith T.F., Waterman M.S. Identification of common molecular subsequences. J. Mol. Biol. 1981, 147:195.
41. Wittig M., Anmarkrud J.A., Kassens J.C., Koch S., Forster M., Ellinghaus E., et al. Development of a high-resolution NGS-based HLA-typing and analysis pipeline. Nucleic Acids Res. 2015.
42. Pyo C.W., Wang R., Vu Q., Cereb N., Yang S.Y., Duh F.M., et al. Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics 2013, 14:89.
43. Pyo C.W., Guethlein L.A., Vu Q., Wang R., Abi-Rached L., Norman P.J., et al. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One 2010, 5:e15115.
44. Dommaraju K., Kijak G., Carlson J.M., Larsen B.B., Tovanabutra S., Geraghty D.E., et al. CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants. PLoS One 2014, 9:e111334.
45. *02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial. J. Virol. 2014, 88:8242.
46. Siva N. UK gears up to decode 100000 genomes from NHS patients. Lancet 2014.
47. Torjesen I. Genomes of 100,000 people will be sequenced to create an open access research resource. BMJ 2013, 347:f6690.
48. Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G., Parham P., Madrigal J.A., et al. Cloning and sequencing full-length HLA-B and -C genes. Tissue Antigens 2003, 61:20.
49. Pohl M., Bortfeldt R.H., Grutzmann K., Schuster S. Alternative splicing of mutually exclusive exons - a review. Biosystems 2013, 114:31.
50. Chen C.Y. DNA polymerases drive DNA sequencing-by-synthesis technologies: both past and present. Front. Microbiol. 2014, 5:305.
51. Li S.S., Gilbert P.B., Tomaras G.D., Kijak G., Ferrari G., Thomas R., et al. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. J. Clin. Invest. 2014, 124:3879.
52. UK catapults precision medicine, Nat. Biotechnol. 33 (2015) 119.
53. Collins F.S., Varmus H. A new initiative on precision medicine. N. Engl. J. Med. 2015.
54. Pagani I.S., Spinelli O., Mattarucchi E., Pirrone C., Pigni D., Amelotti E., et al. Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in chronic myeloid leukemia. Oncoscience 2014, 1:510.
55. Rieneck K., Bak M., Jonson L., Clausen F.B., Krog G.R., Tommerup N., et al. Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma. Transfusion 2013, 53:2892.